These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10747831)

  • 21. [Development of multi-drug resistant mutants of clinical isolates of Pseudomonas aeruginosa after exposure to fluoroquinolone].
    Hasegawa M; Kobayashi I; Saika T; Shimadzu M; Nishida M
    Kansenshogaku Zasshi; 1996 Feb; 70(2):123-31. PubMed ID: 8851384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Bachoual R; Ouabdesselam S; Mory F; Lascols C; Soussy CJ; Tankovic J
    Microb Drug Resist; 2001; 7(3):257-61. PubMed ID: 11759087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
    Levy DD; Sharma B; Cebula TA
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro.
    Hansen H; Heisig P
    Microb Drug Resist; 2003; 9(1):25-32. PubMed ID: 12705680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of a new difluorinated quinolone: lomefloxacin (SC-47111).
    Mattina R; Cocuzza G; Cocuzza CE
    J Chemother; 1989 Jul; 1(4 Suppl):159-61. PubMed ID: 16312351
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.
    Lecso-Bornet M; Pierre J; Sarkis-Karam D; Lubera S; Bergogne-Berezin E
    Antimicrob Agents Chemother; 1992 Mar; 36(3):669-71. PubMed ID: 1622183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
    Yoshida S; Kojima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Feb; 35(2):368-70. PubMed ID: 2024969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial characterisation of the acrAB locus in two Citrobacter freundii clinical isolates.
    Sánchez-Céspedes J; Vila J
    Int J Antimicrob Agents; 2007 Sep; 30(3):259-63. PubMed ID: 17631985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.
    Moniot-Ville N; Guibert J; Moreau N; Acar JF; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Mar; 35(3):519-23. PubMed ID: 2039202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
    Weigel LM; Anderson GJ; Facklam RR; Tenover FC
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae.
    Broskey J; Coleman K; Gwynn MN; McCloskey L; Traini C; Voelker L; Warren R
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():95-9. PubMed ID: 10824039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolone resistance in clinical isolates of Serratia marcescens.
    Fujimaki K; Fujii T; Aoyama H; Sato K; Inoue Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 May; 33(5):785-7. PubMed ID: 2546493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Akasaka T; Tanaka M; Yamaguchi A; Sato K
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods.
    Wang JT; Chang SC; Chen YC; Luh KT
    J Microbiol Immunol Infect; 2000 Dec; 33(4):258-62. PubMed ID: 11269372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex Class 1 Integron Carrying qnrB62 and blaVIM-2 in a Citrobacter freundii Clinical Isolate.
    Lee JJ; Kim MN; Park KS; Lee JH; Karim AM; Park M; Kim JH; Lee SH
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6937-6940. PubMed ID: 27572415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinolone resistance in veterinary isolates of Salmonella.
    Griggs DJ; Hall MC; Jin YF; Piddock LJ
    J Antimicrob Chemother; 1994 Jun; 33(6):1173-89. PubMed ID: 7928811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones.
    Ruiz J; Jurado A; Garcia-Méndez E; Marco F; Aguilar L; Jiménez de Anta MT; Vila J
    J Antimicrob Chemother; 2001 Oct; 48(4):545-8. PubMed ID: 11581235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.